COVID-19 pandemic has increased mental health burden on family and friends of patients

Family members and close friends of people with COVID-19 have elevated symptoms of depression and anxiety, a study from Karolinska Institutet published in The Lancet Regional Health – Europe reports.

Sharp Services announces expansion in Pennsylvania to facilitate growth in sterile injectable market – Pharmaceutical Technology

Sharp Services’ Macungie, PA site in North America. Credit: Sharp Services The expansion at Macungie will offer increased capacity for secondary packaging activities including Vial Labeling, Pre-Filled

June 26, 2024

10 Key 2023 Psychedelic Studies Reveal Optimal Psilocybin Doses for Depression

Psychedelic research is flourishing again, and mainstream Americans may soon feel its impact. MDMA is near the regulatory finish line thanks to MAPS’s recent new

December 13, 2023

FibroGen sells China unit to AstraZeneca for $160m – Pharmaceutical Technology

FibroGen’s headquarters in San Francisco, US. Credit: Sundry Photography via Getty Images. AstraZeneca has agreed to acquire FibroGen’s China subsidiary for approximately $160m, securing full

February 22, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.